Novel Insights into the Nobilamide Family from a Deep-Sea Bacillus: Chemical Diversity, Biosynthesis and Antimicrobial Activity Towards Multidrug-Resistant Bacteria
Marine Drugs · 14.01.2025 · 23 (1) · 41
DOI: 10.3390/md23010041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 14.01.2025. Verfasst von Vincenza Casella und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ecosustainable Marine Biotechnology, Stazione Zoologica Anton Dohrn, Via A.F. Acton, 55, 80133 Naples, Italy. Hauptthemen laut MEDLINE: Bacillus, Anti-Bacterial Agents, Peptides, Cyclic, Depsipeptides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, H2020-FNR-11-2020.
Abstract (Originalsprache)
With rising concerns about antimicrobial resistance, the identification of new lead compounds to target multidrug-resistant bacteria is essential. This study employed a fast miniaturized screening to simultaneously cultivate and evaluate about 300 marine strains for biosurfactant and antibacterial activities, leading to the selection of the deep-sea Bacillus halotolerans BCP32. The integration of tandem mass spectrometry molecular networking and bioassay-guided fractionation unveiled this strain as a prolific factory of surfactins and nobilamides. Particularly, 84 nobilamide congeners were identified in the bacterial exometabolome, 71 of them being novel metabolites. Among these, four major compounds were isolated, including the known TL-119 and nobilamide I, as well as the two new nobilamides T1 and S1. TL-119 and nobilamide S1 exhibited potent antibiotic activity against various multidrug-resistant Staphylococcus strains and other Gram-positive pathogens, including the foodborne pathogen Listeria monocytogenes. Finally, in silico analysis of Bacillus halotolerans BCP32 genome revealed nobilamide biosynthesis to be directed by a previously unknown heptamodular nonribosomal peptide synthetase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ecosustainable Marine Biotechnology, Stazione Zoologica Anton Dohrn, Via A.F. Acton, 55, 80133 Naples, Italy.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres, 31, 98166 Messina, Italy.
ORCID-Profile: Gerardo Della Sala, Carmine Buonocore, Pietro Tedesco, Daniela Coppola, Giovanni Andrea Vitale, Donatella de Pascale, Fortunato Palma Esposito
Förderung
- European Commission
- H2020-FNR-11-2020
Zitieren
APA
Casella, V., Della Sala, G., Scarpato, S., Buonocore, C., Ragozzino, C., Tedesco, P., Coppola, D., Vitale, G. A., de Pascale, D., & Palma Esposito, F. (2025). Novel Insights into the Nobilamide Family from a Deep-Sea Bacillus: Chemical Diversity, Biosynthesis and Antimicrobial Activity Towards Multidrug-Resistant Bacteria. Marine Drugs, 23(1), 41. https://doi.org/10.3390/md23010041
Vancouver
Casella V, Della Sala G, Scarpato S, Buonocore C, Ragozzino C, Tedesco P, et al. Novel Insights into the Nobilamide Family from a Deep-Sea Bacillus: Chemical Diversity, Biosynthesis and Antimicrobial Activity Towards Multidrug-Resistant Bacteria. Marine Drugs. 2025;23(1):41. doi:10.3390/md23010041
BibTeX
@article{Casella2025,
author = {Casella, Vincenza and Della Sala, Gerardo and Scarpato, Silvia and Buonocore, Carmine and Ragozzino, Costanza and Tedesco, Pietro and Coppola, Daniela and Vitale, Giovanni Andrea and de Pascale, Donatella and Palma Esposito, Fortunato},
title = {Novel Insights into the Nobilamide Family from a Deep-Sea Bacillus: Chemical Diversity, Biosynthesis and Antimicrobial Activity Towards Multidrug-Resistant Bacteria},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {1},
pages = {41},
doi = {10.3390/md23010041}
}
EUVIMED